Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-17

FDA Approved: ESTAZOLAM — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Estazolam from Actavis Pharma, Inc., updating the regulatory status of this benzodiazepine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Estazolam (Estazolam)

Snippet

SUPPL AP for ESTAZOLAM (ESTAZOLAM)